Disulfides

serpin family C member 1 ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33169829 In situ detection of protein interactions for recombinant therapeutic enzymes. 2021 Feb 4
2 33822598 Paramount Importance of Core Conformational Changes for Heparin Allosteric Activation of Antithrombin. 2021 Apr 20 1
3 32745482 Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency. 2020 Nov 3
4 27222580 Cellular folding pathway of a metastable serpin. 2016 Jun 7 4
5 22481271 The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency. 2012 Jul 18 1
6 15140129 Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. 2004 Jun 3
7 11870603 Induction of protein aggregation in an early secretory compartment by elevation of expression level. 2002 Apr 20 2
8 9882436 Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of thrombospondin-1 with thrombin-antithrombin III. 1999 Jan 1 1
9 10441134 Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin. 1999 Aug 10 1
10 7896748 Amino acid sequence of porcine antithrombin III. 1994 Nov 1
11 2088576 Location of disulfide bonds in antithrombin III. 1990 Dec 5 6
12 2466666 Monoclonal antibodies against antithrombin III. Identification of their epitopes and effects on antithrombin III activities. 1989 Mar 15 2
13 2544589 Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins. 1989 Jul 5 2
14 2458152 Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. 1988 Sep 1
15 3408716 Properties of thrombin- and elastase-modified human antithrombin III. 1988 May 17 1
16 3110143 Identification of a lysyl residue in antithrombin which is essential for heparin binding. 1987 Jun 15 1
17 3426230 Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition. 1987 Dec 1
18 3654616 Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park". 1987 Oct 5 4
19 3838304 Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. 1985 Feb 25 1
20 3986191 Denaturation behavior of antithrombin in guanidinium chloride. Irreversibility of unfolding caused by aggregation. 1985 Mar 12 1
21 6334690 Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III. 1984 1
22 6693405 The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence. 1984 Jan 25 1
23 6830263 Localization of the disulfide bond in human antithrombin III required for heparin-accelerated thrombin inactivation. 1983 Feb 15 3
24 7426659 Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin. 1980 Sep 9 1